Exact Sciences, Bausch Health & more: 5 GI industry key notes

Here are five updates from gastroenterology companies and practices from the past week:

Exact Sciences expects to post fourth-quarter 2019 revenues between $294 million and $296 million. Read more.

The FDA approved GI Scientific's ScopeSeal Duodenoscope Protective Device, a device that protects the distal end of a duodenoscope during endoscopic retrograde cholangiopancreatography procedures.

Bausch Health wants to center its attention on its ophthalmology efforts, but expects gastroenterology to remain a key driver of its business as well, according to insights presented Jan. 13 at the 38th Annual J.P. Morgan Healthcare Conference. Read more

AbbVie earned the European Commission's approval to acquire Allergan, with one condition: The commission is requiring AbbVie to divest Allergan's brazikumab, an in-development inflammatory bowel disease product.

St. Joseph Hospital in Bethpage, N.Y., and Mercy Medical Center in Rockville Centre, N.Y., named Lynn O'Connor, MD, the new chief of colon and rectal surgery. Both hospitals are part of the Rockville Centre-based Catholic Health Services health system.

More articles on surgery centers:
Healthcare coalition earns charity status, raising funds for surgery center — 5 insights
Medical University of South Carolina opens practice with surgery center — 4 insights
Arkansas hospital breaks ground on ASC — 4 insights  

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months